Kolkata: Nephrocare Health Services IPO had a significant first day of the bidding process of Dec 10. While it managed to attract only 13% bids overall,
it witnessed the Grey market Premium, or GMP, jump to Rs 20 from the level of zero, where it was hibernating for the past seven days. On Dec 10, Nephrocare Health IPO was subscribed 0.21 times in the retail category, 0.00 times in QIB (Ex Anchor) and 0.10 times in the NII category. The bids in the QIB (Qualified Institutional Buyers) is a significant indicator since banks, insurance companies or AMCs are in this category and they have the deep pockets and the analytical skills to dissect a public issue threadbare.
Nephrocare Health Services runs a network of nephrological are under the brand NephroPlus. The IPO intends to raise Rs 871.05 crore via a combination of fresh issue of 0.77 crore shares aggregating to Rs 353.40 crore and an OFS part of 1.13 crore shares amounting to Rs 517.64 crore. Nephrocare Health Services IPO mopped up Rs 260 crore from anchor investors such as SBI Mutual Fund (MF), ICICI Prudential MF, Fidelity Funds, DSP MF, Bandhan MF, The Prudential Assurance Company, Eastspring Investments, Polar Capital Funds, Baroda BNP Paribas MF, SBI Life Insurance and HDFC Life Insurance. The company placed a total of 56.58 lakh shares to 14 mutual funds at Rs 460 apiece.
Nephrocare Health IPO GMP
According to investorgain, in early morning of Dec 11 (the second day of the bidding window), Nephrocare Health IPO GMP stood at Rs 20. Considering a price band of Rs 460, the listing price of Nephrocare Health shares could be Rs 480 and the listing gain could be 4.35%. It indicates a sudden bullishness among investors. The GMP stood at zero between December 3 and 9. However, it must be kept in mind that GMP is an unofficial indicator that can be extremely volatile and does not guarantee any listing gain (or loss).
Nephrocare Health IPO price band, lot size, allotment
The Nephrocare Health IPO price band is Rs 438-460. For a retail investor, the smallest investible lot is 32 shares and it needs an application money of Rs 14,720 based on the upper price band. The smallest lot size for investment by sNII investors is 14 lots or 448 shares and that by bNII investors is 68 lots or 2,176 shares. ICICI Securities is the book running lead manager and Kfin Technologies the registrar to the issue.
Nephrocare Health IPO key dates
IPO bid closes: Dec 12
Cut-off time for UPI mandate confirmation: Dec 12
Allotment: Dec 15
Refund: Dec 16
Credit of shares to demat: Dec 16
Listing: Dec 17
Nephrocare Health business
The company was set up in 2010. It offers dialysis care through a network of clinics across the country and a few international markets. As on September 30 2025, Nephrocare ran 519 clinics of which 51 were located in the Philippines, Uzbekistan and Nepal. In India Nephrocare services are available in 288 cities in 21 states and 4 union territories.
(Disclaimer: This article is only meant to provide information. TV9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, any form of alternative investment instruments and crypto assets.)
